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L polymerase proteinThe large (about 2200 amino acids) L polymerase protein of nonsegmented negative-strand RNA viruses
(order Mononegavirales) has six conserved sequence regions (“domains”) postulated to constitute the
speciﬁc enzymatic activities involved in viral mRNA synthesis, 5′-end capping, cap methylation, 3′
polyadenylation, and genomic RNA replication. Previous studies with vesicular stomatitis virus identiﬁed
amino acid residues within the L protein domain VI required for mRNA cap methylation. In our recent study
we analyzed four amino acid residues within domain VI of the Sendai virus L protein and our data indicated
that there could be differences in L protein sequence requirements for cap methylation in two different
families of Mononegavirales — rhabdoviruses and paramyxoviruses. In this study, we conducted a more
comprehensive mutational analysis by targeting the entire SeV L protein domain VI, creating twenty-four L
mutants, and testing these mutations for their effects on viral mRNA synthesis, cap methylation, viral
genome replication and virus growth kinetics. Our analysis identiﬁed several residues required for successful
cap methylation and virus replication and clearly showed the importance of the K-D-K-E tetrad and glycine-
rich motif in the SeV cap methylation. This study is the ﬁrst extensive sequence analysis of the L protein
domain VI in the family Paramyxoviridae, and it conﬁrms structural and functional similarity of this domain
across different families of the order Mononegavirales.a at Charlotte, Department of
, USA. Fax: +1 704 687 3128.
ili).
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Viruses of the order Mononegavirales include diverse human,
animal and plant pathogens that share structurally similar nonseg-
mented, negative-strand RNA genomes with similar strategies for
viral RNA genome replication, transcription and posttranscriptional
modiﬁcations of viral mRNAs (Lamb and Parks, 2007; Lyles and
Rupprecht, 2007; Whelan et al., 2004). All members of this order
encode the large (L) polymerase protein which has six highly
conserved regions (“domains”) postulated to be responsible for the
speciﬁc enzymatic activities of the viral polymerase complex which
include viral genome replication, transcription, mRNA 5′ capping, cap
methylation and 3′ polyadenylation. Currently, there is no structural
data available for the entire L or any region of L. However, site-
directed mutagenesis and computational analyses support the
multifunctional nature of the L protein as targeted amino acid
substitutions in the different L domains were able to inactivate
individual functions of viral polymerase (Cartee et al., 2003; Cortese
et al., 2000; Grdzelishvili et al., 2005; Li et al., 2005, 2008; Ogino and
Banerjee, 2010; Ogino et al., 2010; Poch et al., 1990; Schnell andConzelmann, 1995; Sidhu et al., 1993; Sleat and Banerjee, 1993;
Smallwood et al., 2002).
Similarly to eukaryotic mRNA, most ofMononegavirales synthesize
mRNA containing a 5′ cap structure methylated at the guanine-N7 (G-
N-7) and 2′-O-adenosine (2′-O) positions. The caps are required for
mRNA stability, and cap methylation, especially at G-N-7 position, is
required for efﬁcientmRNA translation (Gingras et al., 1999; Horikami
et al., 1984; Horikami and Moyer, 1982). The methyltransferase
(MTase) activity was originally mapped to the L protein following the
characterization of two vesicular stomatitis virus (VSV, family
Rhabdoviridae) host range (hr) mutants. These mutants exhibited
severe defects in cap methylation (Horikami et al., 1984; Horikami
and Moyer, 1982), but this function was successfully complemented
with puriﬁed wild type (wt) L protein in vitro, demonstrating that L
possesses the viral mRNA MTase activities (Hercyk et al., 1988). More
recently, computational analyses predicted that the L protein domain
VI has a typical 2′-O MTase fold and identiﬁed a putative K-D-K-E
catalytic tetrad and a glycine-rich motif (GxGxG) as the putative
AdoMet binding site (Bujnicki and Rychlewski, 2002; Ferron et al.,
2002; Martin and McMillan, 2002). These predictions were experi-
mentally conﬁrmed by several studies with the VSV L protein leading
to the identiﬁcation of the amino acid residues important for cap
methylation within domain VI (Galloway et al., 2008; Grdzelishvili
et al., 2005; Li et al., 2005, 2006). Grdzelishvili et al. (2005) showed
that one of the VSV hr mutants, hr1, had a single substitution D to V
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defective in cap methylation. Further site-directed mutagenesis of the
glycine-rich motif and putative K-D-K-E catalytic tetrad by Li et al.
(2005, 2006) showed that they are important for mRNA cap
methylation at both the G-N-7 and 2′-O positions. Most of previous
studies suggest that the L protein uses a single AdoMet binding site for
both G-N-7 and 2′-O MTase activity, and that, at least in VSV, 2′-O
methylation precedes G-N-7 methylation (Rahmeh et al., 2009; Testa
and Banerjee, 1977).
While most of the cap methylation studies were conducted using
VSV, limited studies using Sendai virus (SeV, family Paramyxoviridae)
demonstrated similarities as well as differences in the cap methyla-
tion between these two distantly related viruses. SeV produces mRNA
that is capped and methylated at both the G-N-7 and 2′-O positions
(Takagi et al., 1995), but interestingly, puriﬁed SeV L protein or just its
C-terminal portion retaining domain VI, catalyzed only G-N-7, but not
the 2′-O cap methylation (Ogino et al., 2005). In both VSV and SeV,
alanine substitutions of the lysine upstream of the glycine-rich motif
(also the ﬁrst lysine of a putative K-D-K-E catalytic tetrad) led to cap
methylation defects in these two viruses (Li et al., 2006; Murphy and
Grdzelishvili, 2009). However, while alanine substitutions at the ﬁrst
two positions of the glycine-rich motif (G1804 and G1806) had little
effect on MTase activity in SeV (Murphy and Grdzelishvili, 2009), in
VSV the substitutions at the homologous glycine positions G1670 and
G1672 affected cap methylation at either the G-N-7 or both the 2′-O
and G-N-7 positions (Li et al., 2006). Studies with VSV also identiﬁed a
region upstream of domain VI important for cap methylation
(Grdzelishvili et al., 2006). Interestingly, the recent study showed
that VSV tolerates an insertion of GFP gene between domain VI and
this upstream region, and a recombinant virus with such insertion
showed a normal growth in cell culture but no virion-associated
activity in vitro (Ruedas and Perrault, 2009). The upstream region has
not been studied in SeV as there is no homology in this variable region
between rhabdoviruses and paramyxoviruses, although the L protein
of measles virus (a paramyxovirus) was also reported to tolerate GFP
insertion in a region just upstream of domain VI (Duprex et al., 2002).
To dissect the L protein sequence requirements for cap methyl-
ation in SeV in more detail, we conducted a more comprehensive
analysis by targeting the entire SeV L protein domain VI and created
twenty-four L mutants by site-directed mutagenesis at highly
conserved positions within this domain, using sequence conservation
between L proteins in Mononegavirales as a guide (Bujnicki and
Rychlewski, 2002). The L mutations were analyzed in the context of
infectious mutant viruses for their effect on viral mRNA cap
methylation and virus growth in vitro, and we found a good
correlation between attenuation in cell culture and defects in MTase
activity for most of SeV mutants. Our analysis experimentally
conﬁrms previous computational predictions suggesting the impor-
tance of the glycine-rich motif and K-D-K-E tetrad in cap methylation
across different families of the orderMononegavirales. In addition, the
majority of L mutants were tested for their ability to synthesize viral
mRNA and replicate viral genomic RNA. This study is the ﬁrst detailed
analysis of the L protein domain VI in the family Paramyxoviridae.
Results
Site-directed mutagenesis of the SeV L protein domain and recovery of
infectious SeV mutants
In our recent study using SeV we targeted four amino acid residues
in domain VI and showed a discrepancy between VSV and SeV in their
L protein sequence requirements for cap methylation (Murphy and
Grdzelishvili, 2009). In this work, we analyzed the entire domain VI of
SeV in more detail, targeting the residues highly conserved in most
members of the order Mononegavirales (Fig. 1). In addition to
targeting the glycine-rich motif (the putative AdoMet binding site)and the putative catalytic tetrad K-D-K-E, which also is conserved in
other known 2′-O MTases including NS5 protein of ﬂaviviruses
(Fig. 1), we also targeted residues D1799 and Y1802 located just
upstream of the glycine-rich motif and conserved only in some
paramyxoviruses (Fig. 1). Many classes of MTases of known structure
contain either a conserved aspartate or glutamate, or a tyrosine
residue within the beta strand that precedes the conserved glycine-
rich motif, but rarely do they contain both these residues. A polar
residue in this position has been implicated in reaction mechanism as
the ﬁfth catalytic entity (Kozbial and Mushegian, 2005), and we were
interested in determining whether one or both of these amino acids
may play a functional role in SeV MTase. We also targeted the DKDK
sequence located immediately upstream of the residue D1799.
Although this DKDKD sequence is present only in some paramyx-
oviruses, wewanted to determinewhether such high concentration of
aspartates and lysines and its close proximity to the glycine-rich motif
may play some role in cap methylation catalysis. In addition to single
amino acid substitutions, several double and triple alanine substitu-
tions were created, and the glycines within the glycine-rich motif
were changed to leucines to address a possibility that this motif, while
important for cap methylation in SeV, is more tolerant to single
glycine-to-alanine substitutions as compared to VSV. All told, twenty-
four L mutant genes were generated in the context of the pGEM-L
vector with the L gene under control of the T7 promoter for their
analysis using VVT7 system (see below). In addition, we cloned these
mutations into a SeV full-length antigenomic plasmid, and we were
able to generate 19 infectious SeV mutants using a reverse genetics
system (Table 1). Infectious virus particles could not be recovered for
the remaining ﬁve mutant L genes (indicated as NR in Table 1).Growth analysis of SeV L mutants in Vero cells
All infectious SeV mutants were initially tested for their ability to
infect and produce a cytopathic effect (CPE) in Vero cells. Infectious
foci were visualized by crystal violet staining or IF at 48 or 72 h p.i.
Several mutants behaved similarly to rWT, while some mutants had
obvious defects in growth based on their inability to form visible
infectious foci (Fig. 2A). All of the mutants with the substitutions
between positions 1795 and 1800 (DKDKDR) were capable of forming
visible infectious foci and grew to rWT-like titers (Fig. 2A and Table 1).
The rG1804A, rE1805A, rG1806A mutants and the double-mutant
rG1804A/G1806A behaved as in our previous report (Murphy and
Grdzelishvili, 2009), i.e., they showed similar growth to rWT. Even the
rE1805Amutant, which had a slight delay in growth, still grew to high
titers. Additional alanine mutants in or around glycine-rich motif
behaved with minor variations: the rG1808A and especially the triple
mutant rG1804A/G1806A/G1808A had smaller than rWT infectious
foci, but grew to a high titer (1.4×108 CIU/ml), and the rY1802A
mutant had small infectious foci 48 h p.i. but at 72 h p.i. had foci size
and titer similar to rWT (Fig. 2B). In contrast to these mutants, leucine
substitutions had dramatic effect on virus growth: E1805L and
G1808L could not be recovered despite all effort; rG1804L was
dramatically attenuated in Vero cells and infectious foci could only be
detected by IF (Fig. 2C); and rG1806L was severely attenuated in cell
culture, and even after several passages on Vero cells, titers remained
extremely low (b102 CIU/ml) (Fig. 2C and Table 1). Thus, the GxGxG
motif, which in the cases of homologous MTases with the known
structure is invariably located in the loop between the ﬁrst beta strand
and the alpha helix of the Rossmann fold, tolerates substitutions to
small side chain residue such as alanine, but the bulkier aliphatic side
chain of leucine appears incompatible with the structure or function
of this region. The rules for E1805 were similar: negative charge
turned out to be unimportant for virus viability, even though this
residue is conserved in all Mononegavirales, but a bulky aliphatic
leucine residue was not tolerated.
Fig. 1. SeV L protein mutants generated and analyzed in this study. Multiple alignment of the L protein domain VI for members of the orderMononegavirales in comparison to theMTase
domain of NS5 protein in ﬂaviviruses. Multiple alignment was conducted using AliBee Multiple Alignment program from the GeneBee website (www.genebee.msu.su/genebee.html)
(Brodsky et al., 1993). The K-D-K-E and glycine-richmotif mutated positions are highlighted in black, while gray shadows indicate other amino acid substitutions generated in this study.
“SeV”: Sendai virus L protein [NCBI gene ID (gi):297180]; “HPIV1 or 3”: human parainﬂuenza virus 1 [gi:19718373] or 3 [gi:3510306]; “CDV”: canine distemper virus [gi:39938470];
“Nipah”: Nipah virus [gi:253559849] “MV”: measles virus [gi:1041625] “RV”: Rinderpest virus [gi:56410436] “NDV”: Newcastle disease virus [gi:11545725]; “HPIV2”: human
parainﬂuenza virus 2 [gi:19525727]; “Mumps”: mumps virus [gi:50404170] “SV41”: Simian virus 41 [gi:55770827]; “HMPV”: human metapneumovirus [gi:46852141]; “RSV”: human
respiratory syncytial virus [gi:1695266]; “VSV”: vesicular stomatitis virus [gi:336028] “Rabies”: rabies virus [gi:237688385] “Ebola”: Ebola virus [gi:10313999] “Marburg”: Marburg virus
[gi:158539115]; 2NYU— ortholog of RNAMTase FtsJ [gi:119390696]; “WNV”: West Nile virus [gi:27735310] “JEV”: Japanese encephalitis virus [gi:189086643] “Dengue”: Dengue virus 2
[gi:158851624]. 2NYU_second: secondary structure elements observed in the three-dimensional structure of the humanortholog of RNAMTase FtsJ (PDB code2NYU) are shown: h stands
for alpha helix, s stands for beta strand, and l stands for loop.
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substitution at the ﬁrst position of the putative K-D-K-E catalytic
tetrad, rK1782A, was attenuated in cell culture (Murphy and
Grdzelishvili, 2009). Here we created alanine substitutions at the
other positions of this motif and rescued viruses with substitutions at
the D1901 and K1938 positions; however, we were not able to rescue
a virus with a mutation at E1975. Interestingly, after sequencing, the
K1938 position mutant had a substitution to serine and not alanine.
This serine substitution apparently has been selected in vivo, as the
input plasmids used for virus recovery were conﬁrmed by sequencing
to have the alanine substitution. In addition to targeting the K-D-K-E
tetrad, we created alanine mutants of two other positions invariant in
Mononegavirales, S1777 and E1903, and a double mutant, rK1938A/
I1939L. All SeV L mutants with substitutions in and around this
putative K-D-K-E catalytic tetrad were attenuated when grown onVero cells (Fig. 2A). rK1782A, rE1903A, and rK1938A/I1939L
produced infectious foci detectable only by IF (Fig. 2C).
The amino acids of the K-D-K-E tetrad are widely spaced in the
sequence of virus MTase, but are brought to close distance in the
homologous MTases of the known structure and in the predicted
spatial structures of the L domain VI proteins (Bujnicki and
Rychlewski, 2002; Galloway et al., 2008). They form a semi-circle on
the outer rim of the AdoMet binding pocket and are thought to work
together in transferring the methyl group from that donor to the 5′
nucleotides of virus mRNA, though exact role of each residue, as well
as the details of the reaction mechanism (and indeed, the native
three-dimensional structures of MTases of Mononegavirales), remain
to be investigated. Residues S1777 and E1903 are predicted to be
further outwards from the AdoMet binding pocket, and may be
expected not to interact with the methyl donor, but rather perhaps
Table 1
Cap methylation analysis using SeV detergent-activated puriﬁed virions.
Viruses Virus stock infectivity
(CIU/ml)
Txn−AdoHcy
(% of rWT−AdoHcy)
Txn+AdoHcy
(% of rWT−AdoHcy)
† Cap Methylation−AdoHcy
(% of rWT−AdoHcy)
† Cap Methylation+AdoHcy
(% of rWT−AdoHcy)
rWT 3.8×108 100.0 67.0±26.0 100.0 2.7±0.2
rS1777A 4×107 100.0±25.8 70.3±5.2 45.8±11.9 0.7±0.2
rK1782A* 2×105 25.8±2.6 32.8±11.7 6.6±1.2 1.4±0.7
rD1795A 8×107 55.4±12.4 51.3±17.0 51.6±16.9 1.7±0.6
rK1796A 8×107 54.0±13.5 41.6±3.9 82.2±13.2 1.7±0.3
rD1797A 8×107 79.4±0.5 64.4±25.2 120.9±20.8 2.7±0.1
rK1798A 1×108 48.9±7.1 24.8±0.5 104.0±0.8 4.2±0.6
rD1799A 1.4×107 64.2±12.7 53.1±15.1 80.2±19.8 2.7±0.4
rR1800A 4.8×107 70.1±7.3 70.7±9.9 48.5±17.8 1.5±1.0
rY1802A 1.4×108 14.6±5.6 15.4±3.0 7.2±0.5 1.8±1.7
rG1804A* 3.4×107 nd nd nd nd
rG1804L 1×106 27.9±4.6 30.1±5.8 9.9±0.7 1.2±0.5
rE1805A* 3.2×107 34.0±15.8 50.0±2.8 22.8±5.2 5.3±5.7
rE1805L NR NR NR NR NR
rG1806A* 2.2×108 nd nd nd nd
rG1806L b102 nd nd nd nd
rG1808A 8×107 21.8±8.2 18.1±6.3 31.4±0.1 1.8±1.5
rG1808L NR NR NR NR NR
rG1804A/G1806A* 8×107 114.8±5.9 86.8±12.8 50.9±1.6 12.5±0.3
rG1804A/G1806A/G1808A 1.4×108 25.0±5.0 17.2±3.1 36.8±5.0 2.1±0.5
rY1825A/N1826A/S1827A NR NR NR NR NR
rW1876A 1.6×108 20.3±2.8 21.9±6.2 46.8±10.3 1.5±0.3
rT1875A/W1876A NR NR NR NR NR
rD1901A 1.4×107 37.4±5.7 27.3±4.9 2.1±0.5 0.2±0.3
rE1903A 4×105 26.1±4.4 27.3±3.5 7.3±2.4 0.2±0.5
rK1938S 1.2×106 91.0±12.7 60.1±3.1 8.1±0.9 2.2±0.6
rK1938A/I1939L 1.2×106 46.9±23.2 28.4±16.1 2.4±0.5 1.1±0.4
rS1969A 4.4×107 71.5±10.1 67.0±12.4 73.7±20.9 2.1±0.1
rE1975A NR NR NR NR NR
rY1977A 8×107 55.5±16.7 48.5±23.2 28.6±5.7 5.1±3.3
− AdoHcy: in vitro transcription in the absence of S-adenosylhomocysteine (AdoHcy).
+ AdoHcy: in vitro transcription in the presence of 100 μM AdoHcy.
† methylation of viral mRNA (NP+P) produced in vitro is expressed as the ratio (% of rWT) of [3H]-AdoMet incorporation into viral mRNA by scintillation counting to the mRNA
levels determined analyzed by Northern blot (mRNA levels are shown in the “Txn” columns).
NR = not rescued (unable to rescue after multiple attempts).
nd = not determined.
*Viruses were also analyzed in our previous study (Murphy and Grdzelishvili, 2009).
CIU = cell infectious units.
The data represent the mean±standard deviation of two independent experiments.
373A.M. Murphy et al. / Virology 405 (2010) 370–382play a role in recognition of the RNA substrate. Our results indicate
that single alanine mutations in most of these residues result in
attenuation of virus infection.
We also recovered several mutants with alanine substitutions at
other invariant positions of domain VI, i.e., W1876A, S1969A, and
Y1977A. These mutant viruses behaved similarly to rWT in Vero cells
and grew to high titers (Fig. 1A and Table 1). The corresponding
residues are predicted to be located outside of the ligand-binding
pocket and may not be involved in any intramolecular interactions.
We, however, were unable to recover virus progeny in the mutants
that had multiple alanine substitutions in these patches of amino
acids predicted to face outwards, i.e., a triple substitution Y1825A/
N1826A/S1827A or a double substitution T1875A/W1876A. These
highly conserved regions might be necessary for interactions of SeV
MTase with other regions within the L protein or with other proteins.
To further examine the growth characteristics of all rescued
mutant viruses, a one-step growth kinetics analysis was performed as
described in Materials and methods (Fig. 3). rWT reached its highest
titer at 48 h p.i. and then declined at 72 and 96 h p.i. Mutants with
substitutions within the DKDKD sequence upstream of the glycine-
rich motif had slightly lower titers than rWT overall, but still reached
their highest titers at 48 h p.i. (Fig. 3A). Formutantswith substitutions
in the glycine-rich motif, the majority behaved similarly to rWT with
slightly lower titers overall and maximum titers (107–108 CIU/ml)
reached at 48 h p.i. (Fig. 3C). rG1804L was severely attenuated with
infectious particles detected only after 24 h p.i. and maximum titers
reaching only 105 CIU/ml at 96 h p.i. L mutants with substitutions in
and around the putative K-D-K-E catalytic tetrad were delayed ingrowth and had dramatically lower maximum titers (104–105 CIU/
ml) as compared to rWT.
Correlation between virus attenuation and defects in cap methylation
To determine whether the L mutations affected the ability of
viruses to methylate mRNA 5′ cap structures, in vitro transcription
was performed using detergent-activated puriﬁed virions in the
presence of [3H]-AdoMet with or without S-adenosylhomocysteine
(AdoHcy), a competitive inhibitor of AdoMet-dependentMTases. RNA
products were isolated and analyzed by scintillation counting for [3H]-
AdoMet incorporation and by Northern blot for total mRNA levels
(Table 1). Cap methylation activity of each L mutant protein was
expressed as a ratio of [3H]-AdoMet incorporation into viral mRNA to
the NP+P mRNA products (Table 1, columns 5 and 6). This
normalization was done to account for variability in overall
transcription levels between different viruses (Table 1, columns 3
and 4). This variability could be due to mutations speciﬁcally effecting
viral mRNA synthesis or due to variability in the transcriptional
activity of individual virion preparations (see below).
Unfortunately, a high-resolution analysis of cap structure in SeV
mRNA is beyond our reach due to the more than 200-fold lower
abundance of mRNA produced by SeV virion-associated L protein as
compared to VSV (Murphy and Grdzelishvili, 2009). However, to
conﬁrm that [3H]-labeled SeV mRNA (Table 1) had methylated cap
structure, we analyzed [3H]-AdoMet labeled mRNA generated as
described above, using tobacco acid pyrophosphatase (TAP) (Fig. 4).
TAP is commonly used to speciﬁcally remove the 5′-terminal
Fig. 2. Growth analysis of recombinant SeV mutants in Vero cells. (A) Crystal violet staining of infectious foci of all rescued SeV L mutants. Plaque assays were performed on Vero cells and
infectious foci from the lowest dilution displaying infectious foci were stained 48 h p.i.Wells with no visual infectious foci at 48 h p.i. were analyzed at 72 h p.i. or by IF. (B) For delayedmutants
(indicatedby*), plaqueassayswereagainperformedandcrystal violet stainingof infectious fociwasdoneat72 hp.i. (C)For severelyattenuatedmutants thathadnovisible infectious foci at48or
72 hp.i. an IF assaywas performed at 72 hp.i. Upper panels represent cells stainedwith an anti-SeVprimary antibody and an IgG secondary antibody conjugated to FITC. Lower panels represent
Hoeschst staining of nuclei from the same ﬁelds shown in upper panels.
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Fig. 3. One-step growth kinetics of SeV mutants in Vero cells. Monolayer cultures of
Vero cells were infected at an MOI of 3 CIU/cell with each mutant SeV. Vero cells
were incubated with viruses for 1 h, then unabsorbed viruses were aspirated, cells were
washed two times with PBS and fresh was added to each well. Supernatants
were collected at 6, 24, 36, 48, 72, and 96 h p.i. and ﬂash frozen. Plaque assays were
performed on Vero cells and virus titers were determined for each time interval. * Zero
titer indicates that virus titer at the indicated time point was below our detection
threshold (50 CIU/ml). (A) SeV mutants with alanine substitutions in a DKDKD motif
upstream of the glycine-rich motif. (B) SeV mutants that showed delayed growth in
Vero cells or lower titers as compared to rWT. (C) SeVmutants with substitutions in and
around the glycine-richmotif. The data represent themean±standard deviation of two
independent experiments.
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mRNA cannot serve as a substrate for the TAP (Shinshi et al., 1976). In
addition to SeV mRNA, we used three different control mRNAs(described in detail in Materials and methods): i) [3H]-AdoMet
labeled VSV mRNA generated using detergent-activated wt VSV
virions using in vitro transcription conditions identical to SeV; ii)
synthetic SeV NP mRNA containing Cap 0 (m7GpppA...) structure
labeled with [3H] at the G-N-7 position, and iii) synthetic SeV NP
mRNA containing Cap 1 structure (m7Gppp[m2′-O]A...) labeled with
[3H]-AdoMet only at the 2′-O position (2′-O methylated by the
vaccinia virus enzyme). For TAP analysis, all these mRNAs were
normalized by [3H] counts and digested by TAP (or mock-treated
using the same conditions by without TAP). Fig. 4 shows [3H] counts
associated with the released 5′-terminal G (“m7G”) or with mRNA
after TAP treatment and separation using Sephadex G-50 columns. As
expected, TAP treatment did not affect an association of [3H] with the
synthetic mRNA having Cap 1 structure (m7Gppp[m2′-O]A...) but
labeled only at the 2′-O position, but resulted in the release of [3H]-
m7G from the synthetic Cap 0 mRNA labeled at the G-N-7 position
(Fig. 4), conﬁrming that TAP speciﬁcally hydrolyzed the phosphoric
acid anhydride bonds in the triphosphate bridge of the cap structure.
Importantly, TAP treatment clearly resulted in the release of [3H]-m7G
from SeV mRNA produced by determent-activated virions in vitro,
indicating that SeV mRNA was at least partially methylated at the G-
N-7 position. A similar result was obtained for VSV virion-produced
mRNA, which is consistent with the previous studies demonstrating
that the fully methylated VSV mRNA has Cap 1 structure (Abraham
et al., 1975; Rahmeh et al., 2009; Testa and Banerjee, 1977).
Although our data (Fig. 4) demonstrate that SeV methylates its
mRNA at least partially at the G-N-7 position, at this point we cannot
make any conclusions about cap structure of SeV mRNA produced
under our experimental conditions. Fig. 4 shows that TAP released
more [3H]-m7G from SeV mRNA than from VSV mRNA, and similar
amounts of [3H]-m7Gwere released from SeVmRNA and the synthetic
Cap 0 mRNA, which could indicate that SeV was methylated
exclusively at the G-N-7 position. However, it would be premature
to make this conclusion based solely on the TAP experiments. Thus,
we did not observe a complete removal of [3H]-m7G from the
synthetic Cap 0 mRNA labeled only at G-N-7 position, indicating that
under our experimental conditions TAP was only about 50% effective
in hydrolyzing triphosphate bridges. Furthermore, mRNA products
analyzed in Fig. 4 were normalized by [3H] counts. However, it is likely
that the efﬁciency of cap methylation is different for SeV, VSV and
vaccinia virus MTases and, therefore, different molar amounts of
capped mRNA were likely present in these reactions further
complicating conclusions about cap structure. Further studies using
alternative biochemical assays are needed to determine cap structure
of SeV mRNA produced under our experimental conditions, although
a dramatic improvement in our in vitro transcription conditions is
needed to obtain sufﬁcient amounts of viral mRNA for cap analysis.
Most of the SeV L mutants of the DKDKD sequence had
methylation levels similar to rWT, while rD1795A and rR1800A had
about a 50% decrease in capmethylation compared to rWT. Consistent
with our previous results (Murphy and Grdzelishvili, 2009), the SeV L
mutant rG1804A/G1806A had only slightly decreased methylation
compared to rWT and the rE1805A mutant had methylation levels
about 23% of rWT. The other SeV Lmutants of the glycine-richmotif all
had lower levels of methylation as compared to rWT ranging from
about 10% for rY1802A and rG1804L to about 40% for rG1808A and
rG1804A/G1806A/G1808A. Except for rS1777A, all SeV L mutants
with substitutions in and around the K-D-K-E tetrad (rK1782A,
rD1901A, rE1903A, rK1938S, and rK1938A/I1939L) were severely
defective in cap methylation (2–8% of rWT). In general, most of the
SeV mutants defective in cap methylation were attenuated in Vero
cells, indicating the importance of this function in the SeV life cycle.
Interestingly, while rWT and most of our mutants showed only
residual mRNAmethylation in the presence of AdoHcy, this value was
surprisingly high (12.5%) for rG1804A/G1806A. At this point, we do
not have an explanation for this result, but it was consistently
Fig. 4. Cap methylation analysis using tobacco acid pyrophosphatase. SeV rWT (“SeV
mRNA”) and VSV rWT (“VSV mRNA”) were produced in vitro transcription by detergent-
activated puriﬁed virions in the presence of [3H]AdoMet. Synthetic SeV NPmRNA controls
were synthesized in vitro using T7 RNA polymerase and then used to make mRNA
containing Cap 0 (m7GpppA...) labeled with [3H]AdoMet at the G-N-7 position, or mRNA
containing Cap 1 (m7Gppp[m2′-O]A...) labeled with [3H]AdoMet only at the 2′-O position
using vaccinia virus enzymes as described in Materials and methods. For TAP analysis, all
RNAs were normalized by [3H] counts and digested by TAP (“+TAP”) or mock-treated
using the same reactions but without TAP (“-TAP”). mRNA was then separated from [3H]
m7G using Sephadex G-50 mini-columns. [3H]Met incorporation into the G-N-7 or 2′-O
cap positions was measured by scintillation counting of the entire ﬂow through (for
mRNA containing [3H-m2′-O]A) and columns (for removed [3H]m7G). The data represent
the mean±standard deviation of two independent experiments.
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an interesting possibility that this mutation improves the preference
of L towards AdoMet over AdoHcy, making it less sensitive to the
excess of this product. Further studies are needed to address this
possibility.
Analysis of the ability of expressed L proteins to synthesize viral mRNA
and replicate genomic RNA in vitro
To examine the abilities of L mutants to synthesize viral genomic
negative-stranded, as well as mRNA, we selected 15 different
mutations resulting in virus attenuation in Vero cells, or low cap
methylation levels, or “not rescued” phenotype (Table 1), and
analyzed the effects of these mutations on L function using plasmid
based expression assays, which do not depend on the viability of SeV
mutant viruses. These assays are based on the exogenously provided
polymerase-free wt genomic (for transcription) or DI (for replication)
RNA-N template and cell extracts containing T7 RNA polymerase-
expressed SeV L (wt or mutant), P and NP (for DI replication only)
proteins as described in Materials and methods. Brieﬂy, A549 cells
were infectedwith vaccinia virus (VV) expressing T7 polymerase (VV-
T7), transfected with SeV P wt and L (wt or mutant) and NP wt (only
for DI replication), and incubated at 34 °C. At 18 h p.t., cytoplasmic
extracts, containing P-L or NP-P-L complexes, were prepared and
supplied with the exogenous wt SeV polymerase-free RNA-N
template (genomic or DI) and [α32P]CTP to assay for mRNA or DI
RNA synthesis.
In agreement with their putative lethal phenotype (unable to
rescue mutant viruses having these mutations after about 20
independent attempts), two L mutations — E1805L and G1808L, as
well as earlier described mutant ΔVI (SeV L protein with the entire
domain VI deleted) (Murphy and Grdzelishvili, 2009) produced nodetectable mRNA and were also defective in genomic RNA replication
(b5% of rWT) (Fig. 5). The E1975A mutant L protein, which could also
not be rescued in vivo, had wt-like levels of transcription in the VV-
mediated system, but replication levels were 10% of rWT. Several
other mutant L proteins had transcription levels higher than 50% of
rWT but lower levels of replication (b40% of rWT) including D1901A,
E1903A, and K1938A/I1938L (but not K1938S), all of which are
members of the K-D-K-E catalytic tetrad. G1804L, E1805A, G1806L,
and G1804A/G1806A/G1808A, all members of the glycine-rich motif,
had similar levels of transcription and replication ranging from 30 to
60% of rWT. Intriguingly, the Y1802A mutant was less than 10% active
in transcription and replication even though virions bearing this
mutation were recovered and grew to similar titers as compared to
rWT. This indicates that the intactness of the primary AdoMet binding
site and the majority of the catalytic residues are required for multiple
functions of L protein, most likely including synthesis of the negative-
strand genomic RNA and its transcription into mRNAs. Only two
mutant L proteins, S1777A and K1782A, had rWT levels of transcrip-
tion and replication, indicating a more limited role of the predicted
ﬁrst helix in the Rossmann fold in SeV RNA synthesis.
Interestingly, we observed that many amino acid substitutions
negatively affected L protein accumulation in the plasmid based
expression assays. Some of these mutations could potentially affect L
gene expression or L protein stability of the protein, which could
impact viral RNA synthesis. However, we did not see any clear
correlation between L protein levels and transcriptional activities for
most mutant proteins (Fig. 5). Interestingly, the lowest protein
accumulation (26% of wt) was shown for the K1938A/I1939L
mutation; however, it had 107% transcriptional activity. At the same
time, this mutant showed only 14% DI replication activity suggesting a
possibility that L protein accumulation may speciﬁcally affect
replication (but not transcription) activity of viral polymerase.
However, other two mutations, E1903A and E1975A, which had
disproportionally low DI replication activities (relative to transcrip-
tion), did not show any dramatic decreases in protein accumulation
(Fig. 5).
Superinfection analysis
To test whether SeV mutants with substitutions at different
positions within domain VI could potentially complement each other
when grown together, we infected Vero cells with various combina-
tions of defective mutants at an MOI of 1 CIU/cell per virus (total MOI
of 2). Under this conditions, most of the cells are co-infectedwith both
viruses. In addition to viruses with the phenotypes described above,
we included rWT and other mutants that behaved similarly to rWT as
controls (rS1777A, rR1800A, rE1805A, rG1804A/G1806A/G1808A, and
rY1977A). We did not see any increase in CPE when defective mutants
were combinedwithother defectivemutants (data not shown). Instead,
when two of the defective mutants (rK1938S and rK1938A/I1939L)
were combined with rWT, we observed an inhibition of CPE with less
cell rounding and cells remaining attached to the plastic (data not
shown), suggesting they interferedwith rWT replication. To investigate
it further, we repeated the experiment looking at all SeV L methylation
defective mutants in combination with rWT only (Fig. 6A). All
combinations grew to titers comparable to supernatant collected from
Vero cells infected with rWT only with the exception of K1938S and
K1938A/I1939L which had 99% lower titers for rWT (rWT foci can be
easily discriminated from those generated by mutants due to their
signiﬁcantly larger size and earlier appearance). We then compared
growth kinetics of two mutants, K1938S and K1782A in combination
with rWT by infecting Vero cells and collecting supernatants at 18–72 h
p.i. Similar to our titration experiments (Fig. 6A), K1782A when
combined with rWT had similar growth kinetics to rWT alone while
K1938S in combination with rWT had delayed growth and lower
maximal titers (Fig. 6B), indicating that cap methylation defect alone is
Fig. 5. In vitro mRNA synthesis and genome replication with SeV mutant L proteins using a VVT7 expression system. Plasmids expressing P and wt or mutant L proteins were
transfected into VV-T7 infected A549 cells. N protein was also expressed for DI replication. Total RNA was isolated from cell lysates and in vitro transcription (A) or DI replication (B)
reactions were performed in the presence of [α32P]-CTP. Western blot analyses of cell lysates used in (A) or (B) demonstrate relative expression of the SeV L, P and N (for DI
replication) proteins in A549 cells. Transcription and DI replication data represent the mean±standard deviation of two independent experiments.
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rWT replication and that some additional factors are involved in the
dominant-negative phenotype of these SeV mutants.At this time, we cannot explain why viruses containing amino acid
substitution at the L position 1938 interfere with rWT replication. One
possibility is that such inhibition may simply reﬂect elevated levels of
Fig. 6. Superinfection of Vero cells with SeV mutants. (A) Vero cells were infected with combinations of SeV mutant viruses and rWT at anMOI of 1 CIU/cell (total MOI of 2). Cells were
observed and CPEwas visualized by lightmicroscopy at 24, 48, and 72 h p.i. The supernatant was collected at the same time points and each samplewas further analyzed by plaque assays
performed on Vero cells. Data represent the mean of three independent infections±standard deviation. (B) One-step growth kinetics for rWT grown in combination with K1782A and
K1938Smutant viruseswere analyzed. Vero cellswere infectedatMOI1 CIU/cell (totalMOI of 2), supernatants collected at 18, 24, 48, and72 hp.i. and titeredonVero cells. (C–E)Vero cells
were infectedwith combinationsof SeVmutant virusesplus rWTat anMOIof1 CIU/cell for eachvirus (totalMOI of2). 48 hp.i., cellswereanalyzedbyNorthernblot (D–E)and themedium
was tittered on fresh Vero cells (C). Titrationwas done on 6-well plates (C) with the rWT infection foci visualized 48 h p.i. using 4 CN Peroxidase Substrate staining Kit (KPL) and anti-SeV
primary antibodies. Representative plates are shown. Only large SeV rWT (but not mutant) infectious foci are visible at this time point. (D–E) Cell pellets were analyzed by Northern blot
analysis for genomic RNA using a probe for full-length (FL) genomic RNA (gRNA) as well as DI genomic RNA (D) or a riboprobe for the SeV NP mRNA as well as the FL antigenomic RNA
(agRNA) (E), as described in Materials and methods. “Vero Mock” sample: total RNA isolated frommock-infected Vero cells. 7 μg of total RNA was used for each sample. “Vero wt SeV”
sample: total RNA isolated from Vero cells infected with SeV rWT and collected at 48 h p.i. “DI gRNA” sample: total RNA isolated from a preparation of SeV DI particles (DI-H). This
preparation had some particles containing FL genomic RNA.
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infected Vero cells again (as in Fig. 6A), collected cells and themedium
at 48 h p.i. Consistent with Fig. 6A, both rK1938S and rK1938A/I1939L
inhibited production of rWT as was determined by titration of the
collected medium on fresh Vero cells (Fig. 6B). For analysis of RNA
synthesized during superinfection, both collected supernatants and
cells were analyzed by Northern blot as described in Materials and
methods. To detect DI genomes, a probe complimentary to the ﬁrst 54
5′-nucleotides of the SeV genomic RNA was used, which should beable to detect full-length genomic RNA of SeV as well as DI genomes
independent on the mechanism of their generation. As shown in
Fig. 6D, we were unable to detect any DI genomes in Vero cells under
our experimental conditions. Interestingly, despite clear inhibition of
SeV rWT virion production (Figs. 6A–C), we did not see any
statistically signiﬁcant decrease in SeV NP mRNA accumulation in
the superinfected cells (Fig. 6E) using a probe against coding NP gene
sequences, although a modest decrease in the full-length genomic
RNA (wt plus mutant) levels was observed (Fig. 6D, FL gRNA band). A
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genomic RNA levels was observed when virus particles from the
medium were pelleted by ultracentrifugation, and RNA from these
particles was analyzed by Northern blot as above (data not shown).
Together, out data suggest that rK1938S and rK1938A/I1939L are able
to over-compete rWT during superinfection and, while the mecha-
nism is unclear, this effect is apparently DI-independent.
Discussion
This study is a more detailed sequence–function analysis of the L
protein domain VI in paramyxoviruses than earlier mutagenesis studies
that we are aware of. Despite some differences between VSV and SeV
presented here and in our recent study (Murphy and Grdzelishvili,
2009), our results clearly show the importance of the putative catalytic
tetrad K-D-K-E and glycine-rich motif, thus conﬁrming previous
computational predictions that these regions are important for MTase
function across different families of the orderMononegavirales (Bujnicki
and Rychlewski, 2002; Ferron et al., 2002; Martin and McMillan, 2002).
To analyze domain VI, we conducted site-directed mutagenesis
targeting the residues highly conserved among Mononegavirales,
including the K-D-K-E tetrad and glycine-rich motif, also present in
the known 2′-O cap MTases including NS5 protein of ﬂaviviruses
(Fig. 1) and nonstructural protein 16 of coronaviruses (Decroly et al.,
2008). Similar to VSV, alanine substitutions in the putative K-D-K-E
catalytic tetrad of SeV generated mutant viruses defective in cap
methylation. The K-D-K-E tetrad was previously shown to catalyze a
2′-Omethyl transfer in the known 2′-OMTases, including NS5 protein
of ﬂaviviruses (Bollati et al., 2009; Egloff et al., 2007; Ray et al., 2006;
Selisko et al., 2010) and nonstructural protein 16 of coronaviruses
(Bouvet et al., 2010; Decroly et al., 2008). In West Nile virus (WNV, a
ﬂavivirus), amino acid substitutions of the homologous residues
abolished 2′-O cap methylation by NS5 protein, but had only modest
effect on G-N-7 methylation (Ray et al., 2006; Zhou et al., 2007). In
VSV, similar substitutions abolished both G-N-7 and 2′-O methylation
(Li et al., 2005). This discrepancy between WNV and VSV can be
explained by the different order of methylation events shown for
ﬂaviruses (GpppA→m7GpppA → m7Gppp[m2′-O]A) (Zhou et al.,
2007) and VSV (GpppA→GpppAm→m7Gppp[m2′-O]A) (Li et al.,
2006; Rahmeh et al., 2009; Testa and Banerjee, 1977). While the
inactivation of 2′-O methylation did not signiﬁcantly affect G-N-7
methylation in WNV, it prevented it in VSV where 2′-O methylation
precedes and apparently facilitates subsequent G-N-7 methylation
(Rahmeh et al., 2009). A high-resolution analysis of cap structure in
SeV mRNA is still beyond our reach due to the more than 200-fold
lower abundance of mRNA produced by SeV virion-associated L
protein as compared to VSV (Murphy and Grdzelishvili, 2009).
However, the critical importance of K-D-K-E tetrad for the overall
cap methylation in SeV presented in this study may indicate that the
SeV L protein catalyzes cap methylation using the same order as VSV
(GpppA→GpppAm→m7Gppp[m2′-O]A).
Our data also demonstrates the importance of glycine-rich motif
(putative AdoMet binding site of domain VI) in SeV capmethylation but
with different effect of mutations in the glycine-rich motif in SeV as
compared to VSV. For VSV, it was shown that virions with alanine
substitutions at the ﬁrst two glycines had decreased cap methylation,
while alanine substitution at the third glycine did not affect MTase
activity (Li et al., 2006). Here, we determined that the third glycine of the
glycine-rich motif seems to play a more signiﬁcant role in cap
methylation in SeV than VSV, decreasing cap methylation by about 70%
(compared to rWT). As further conﬁrmation of the importance of this
position, a triple mutant with all three glycines substituted to alanines
alsohad lowmethylation levels (37%of rWT)while adoublemutantwith
only the ﬁrst two glycines substituted to alanines had rWT-like levels of
growth and higher methylation. Our previous partial results showed so
much tolerance to substitution in theﬁrst twoglycines in the glycine-richmotif as to even doubt that this is a functional AdoMet binding site
(Murphy andGrdzelishvili, 2009). Our data presentedhere, including the
role of the third glycine in the SeV capmethylation and dramatic effect of
glycine-to-leucine substitutions in thismotif restore amore conventional
view of the role of this conserved sequence motif.
Another mutation resulting in defective cap methylation (10% of
rWT) and virus attenuation was Y1802A. This residue has never been
studied before in any Mononegavirales and is highly conserved in most
paramyxoviruses. It possesses a hydroxyl group and may substitute for
the aspartic or glutamic acid residues frequently found in the middle of
the ﬁrst beta strand of the Rossmann fold. It has been proposed (Kozbial
and Mushegian, 2005) that the side chain of this residue makes either
direct or water molecule-mediated contact with the methionine portion
of AdoMet and may be directly involved in catalysis. In several
paramyxoviruses, just next to this residue there is a motif DKDKD1799
with potential importance in catalysis due to the high concentration of
aspartates and lysines and its close proximity to the glycine-rich motif.
We targeted these positions for substitution to alanines, but all these SeV
Lmutants were easily recovered, grew to high titerswith similar kinetics
to rWT in Vero cells and had high levels of cap methylation.
Consistent with the role of cap methylation in the translatability of
mRNA, SeV mutants with decreased methylation (b10%) were
attenuated in Vero cells. The majority of these mutants had
substitutions in and around the putative K-D-K-E catalytic tetrad. In
agreement with our recent study (Murphy and Grdzelishvili, 2009),
we observed that alanine substitutions at positions in and around the
glycine-rich motif were well tolerated; however, a triple mutant with
all three glycines replaced with alanines did show slight attenuation,
conﬁrming the importance of this motif for SeV L function and virus
replication. We also observed that two cap methylation defective
mutants, rK1938S and rK1938A/I1939L, had strong interfering effect
on replication of wt SeV during superinfection. Interestingly, another
cap methylation defective mutant, rK1782A, did not interfere with
rWT replication indicating that cap methylation defect alone is not
sufﬁcient for this dominant-negative mutant phenotype and that
some additional factors are involved. Currently, we cannot explain
how K1938S mutation could inhibit the growth of rWT and further
studies are warranted to explore this interesting observation.
Interestingly, a single alanine substitution at the putative catalytic
K1938 position was successfully introduced into plasmids containing
the SeV L gene and the full-length antigenome of SeV. However, when
infectious virus particles, recovered using a reverse genetics system,
were sequenced, the substitution was to serine rather than alanine.
Based on the importance of this position in the catalytic tetrad, we
speculate that the change to the polar serine residue led to a more
favorable conﬁguration of hydrogen bond network linking catalytic
residues to AdoMet and perhaps additionally supporting proper
conformation of the L protein, whichmay be important for its function.
When tested in a VV-T7 in vitro transcription or replication systems, the
K1938A mutant L had slightly lower transcription (∼80%) and lower
replication levels (∼60%) as compared to rWT. Mutant virions with the
K1938S substitutionwere defective in capmethylation (8% of rWT), but
had high transcription levels (91% of rWT): apparently, a serine
substitution is more favorable for the overall activity of the L protein
(although not necessarily for cap methylation).
A better understanding of the biology of these SeV Lmutants could
lead to the rational design of live attenuated viruses and their use as
vaccine, oncolytic and gene therapy vectors based on different
members of Mononegavirales.
Materials and methods
Cell lines and viruses
African green monkey (Vero, ATCC# CCL-81), human lung
carcinoma (A549, ATCC# CCL-185) and BSR-T7/5 cells [derived
380 A.M. Murphy et al. / Virology 405 (2010) 370–382from baby hamster kidney (BHK-21) cells that constitutively express
bacteriophage T7 polymerase (Buchholz et al., 1999)] were used for
virus infections and plasmid transfections. For virus-driven expres-
sion of the bacteriophage T7 RNA polymerase, A549 cells were
infected with T7-expressing vaccinia virus (VV-T7) (Fuerst et al.,
1986). Recombinant wt (rWT) SeV (Fushimi strain) (Leyrer et al.,
1998) was kindly provided by Dr. Wolfgang J. Neubert (Max-Planck-
Institute of Biochemistry, Germany). SeV rWT or mutants were grown
and puriﬁed as described in (Murphy and Grdzelishvili, 2009). SeV
infectivity was measured by virus titration on Vero cells and
expressed as cell infectious units/ml (CIU/ml). For faster growing
SeV mutants, wells were stained with 0.1% Crystal Violet in 10%
formalin for 10 min, washed with PBS and dried. An immunoﬂuores-
cence (IF) assay was used for severely attenuated SeV mutants as
described in (Murphy and Grdzelishvili, 2009). Following IF, 2 μM
Hoechst reagent (Invitrogen) was added to each well for 10 min, cells
were washed with PBS and viewed under a ﬂuorescent microscope.
For one-step growth kinetics, Vero cells were incubated for 1 hour (h)
with SeVwt ormutants at anMOI of 3 CIU/cell in 24well plates. At 1 h
post infection (p.i.), unabsorbed viruses were aspirated, cells were
washed two times with PBS and MegaVir HyQSFM4 serum-free
medium (SFM) (Hyclone) with 4 μg/ml acetylated trypsin (Sigma)
was added to each well. Plaque assays were performed on Vero cells
using supernatants collected at different time points. For superinfec-
tion experiments, virus infection foci were detected by IF as described
above and in (Murphy and Grdzelishvili, 2009) or by 4 CN Peroxidase
Substrate colorimetric staining (KPL). Brieﬂy, cells were ﬁxed in 3%
paraformaldehyde (Sigma) for 10 min and permeabilized for 2 min on
ice. Cells were blocked in PBS with 5% bovine serum albumin (Sigma)
for 20 min and incubated with anti-SeV primary antibodies (1:100)
for 1 h. Cells were then washed, incubated with goat anti-rabbit IgG-
HRP (Jackson ImmunoResearch) secondary antibodies (1:500) for 1 h.
To visualize infectious foci, cells were washed and incubated with
equal volumes 4 CN Peroxidase Substrate and Peroxidase Substrate
Solution B (KPL).
Plasmids and mutagenesis
The pGEM plasmids containing wt genes for SeV NP, L, and Pstop
(expressing P but not C due to a stop codon in the C open reading
frames, and referred to here as wt P), under the control of the T7
promoter have been described previously (Curran et al., 1991). The
pGEM-L plasmid was used for site-directed mutagenesis as described
in (Murphy and Grdzelishvili, 2009). The SeV pTM-NP, pTM-P and
pTM-L plasmids, and the pRS3Gg (Leyrer et al., 1998) full-length SeV
antigenomic plasmid used for the rescue of recombinant SeV viruses
were kindly provided by Dr. Wolfgang J. Neubert (Max-Planck-
Institute of Biochemistry, Germany). The SeV L protein mutations
were introduced into pRS3Gg as described in (Murphy and Grdze-
lishvili, 2009). Recombinant viruses were puriﬁed as in (Grdzelishvili
et al., 2005) and all mutations were conﬁrmed by sequence analysis
for the presence of the desired mutations and absence of any
spontaneous secondary mutations in the L gene. Total protein
concentrations of puriﬁed virions were determined by a Bradford
assay used in conjunction with viral titers to determine infectivity per
total protein (CIU/μg).
In vitro transcription and DI RNA replication with T7-expressed L proteins
To produce cell lysates containing SeV wt P and wt or mutant L
proteins for in vitro transcription, 60-mm dishes of A549 cells were
infected with vaccinia virus (VV)-T7 at MOI of 2.5 CIU/cell for 1 h at
37 °C, washed with Opti-MEM (Gibco), transfected with 1.5 μg of SeV
pGEM-Pstop and 1 μg of pGEM-L (wt L or one of the mutant L genes)
plasmids using lipofectamine (Invitrogen), and incubated at 34 °C in
Opti-MEM. At 18 h p.t., cytoplasmic extracts were prepared exactly asdescribed previously (Chandrika et al., 1995; Grdzelishvili et al.,
2005). To assay for SeV mRNA synthesis, 1 μg of wt SeV polymerase-
free RNA-N template and 18 μCi of [α32P]CTP were added to each
extract, and reactions were incubated for 2 h at 30 °C. To produce cell
lysates containing SeV wt NP, wt P and wt or mutant L proteins for in
vitro replication of SeV defective interfering (DI) RNA, 60-mm dishes
of A549 cells were infected and transfected as above using 5 μg of SeV
pGEM-Pstop, 2 μg SeV pGEM-NP and 0.5 μg of pGEM-L (wt L or one of
the mutant L genes). At 18 h p.t., cytoplasmic extracts were prepared
as for in vitro transcription. To assay for SeV genome synthesis, 2 μg of
detergent disrupted DI-H (Carlsen et al., 1985) and 18 μCi of [α 32P]
CTP were added to each extract, and reactions were incubated for 2 h
at 30 °C and then treated with micrococcal nuclease to digest
unpackaged RNA (mRNA). For both in vitro transcription and DI
replication, total RNA was puriﬁed using Quick-RNA Miniprep (Zymo
Research) and analyzed by 1.5% agarose/6 M urea gel electrophoresis.
Gels were ﬁxed in 7% acetic acid, dried, and quantitated using a
Typhoon 8600 PhosphorImager and ImageQuant software (Molecular
Dynamics).
Cap methylation analysis using puriﬁed SeV virions
SeV in vitro transcription by detergent-activated puriﬁed virions
was conducted as described in (Murphy and Grdzelishvili, 2009). To
test for viral mRNA cap methylation, RNA was synthesized in a 200 μl
reaction with cold NTPs (1 mM each) and 9 μCi of [3H]AdoMet
(81.5 Ci/mmol, 0.55 μM AdoMet ﬁnal concentration) in the presence
or absence of 100 μM of the methylation inhibitor S-adenosylhomo-
cysteine (AdoHcy). Total RNA was puriﬁed using the Mini RNA
Isolation II Kit (Zymo Research), diluted in 60 μl of diH2O, and used for
measurement of [3H]AdoMet incorporation by scintillation counting
(50 μl) or analyzed by Northern blot to measure viral mRNA levels
(5 μl).
To generate viral mRNA for cap analysis using tobacco acid
pyrophosphatase (TAP), SeV rWT and VSV rWT in vitro transcription
by detergent-activated puriﬁed virions was performed as described
above using [3H]AdoMet and the same reaction conditions for SeV and
VSV. VSV mRNA was synthesized in a 100 μl reaction. To obtain
sufﬁcient amounts of SeV mRNA for this analysis, ten 200-μl
transcription reactions were used for SeV rWT, and viral mRNA
products were isolated and pooled together for TAP treatments. For
preparation of synthetic mRNA controls, uncapped SeV NP mRNAwas
synthesized in vitro with the MAXI-Script T7 kit (Ambion) using SeV
pGEM3-NP plasmid digested at the BamHI restriction site located
immediately after the stop codon for the NP gene as a template. This
RNAwas divided to generate: i) Cap 0 containing mRNA (m7GpppA...)
labeled with [3H] only at the G-N-7 position, or ii) Cap 1 containing
mRNA (m7Gppp[m2′-O]A...) labeled with [3H] only at the 2′-O position.
To make synthetic mRNA containing Cap 0, uncapped mRNA
transcripts were capped and G-N-7 methylated in the presence of
1.75 μM [3H]AdoMet using the ScriptCap m7G Capping System
(Epicentre Biotechnologies) based upon the tri-functional vaccinia
virus capping enzyme, and puriﬁed using Spin-50 Sephadex G-50
mini-columns (USA Scientiﬁc). To make synthetic mRNA with Cap 1
but [3H]-labeled only at the 2′-O position, uncappedmRNA transcripts
were ﬁrst capped in the presence of 100 μM cold AdoMet using the
ScriptCapm7G Capping System tomakemRNAwith the unlabeled Cap
0 structure (which is the template for 2′-O methylation by the
vaccinia virus 2′-O MTase). After puriﬁcation using Spin-50 Sephadex
G-50 mini-columns, the unlabeled Cap 0 mRNA was 2′-O methylated
in the presence of 1.75 μM [3H]AdoMet using ScriptCap 2′-O MTase
(Epicentre Biotechnologies) based upon the vaccinia virus 2′-O
MTase, and puriﬁed again using Spin-50 Sephadex G-50 mini-
columns.
For TAP analysis, virion-produced viral mRNA (SeV or VSV) and
synthetic (G-N-7 or 2′-O labeled) mRNAs were normalized by [3H]
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reactions in the presence or absence of 5 U of TAP for 1 h at 37 °C. All
reactions were then adjusted to 25 μl and passed through Spin-50
Sephadex G-50 mini-columns. Spin columns were then placed in new
microfuge tubes and 25 μl diH2O was passed each column to retrieve
the residual column-bound RNA. Separate optimization experiments
demonstrated effective separation of RNA from nucleotides using this
procedure (data not shown). [3H]Met incorporation into the G-N-7 or
2′-O cap position was measured by scintillation counting of the entire
ﬂow through (contained mRNA) and the Sephadex G-50 column
material removed from mini-columns after separation (contained
removed G).
Northern blot analysis
Northern blot analysis was conducted as described in (Murphy and
Grdzelishvili, 2009) to measure mRNA levels from in vitro transcrip-
tion reactions with [3H]AdoMet (described above). Brieﬂy, mRNA
products were separated on a 1.2% agarose–formaldehyde gel,
transferred to a Hybond-N+ nylon membrane (GE Healthcare), and
incubated with an RNA probe complementary to the SeV NP gene. The
probe was synthesized by digestion of the SeV pGEM3-NP plasmid at
the EcoRV restriction site and transcribed in vitro in the presence of
[α-32P]-CTP using the MAXI-Script SP6 kit (Ambion). For analysis of
RNA synthesized during superinfection, both supernatants and cells
were collected at 48 h p.i. Virus particles in the supernatant were
pelleted by centrifugation at 50,000 rpm for 1 h using a Beckman TLA
100.2 rotor and total RNA was extracted from both cells and pelleted
virions using the Zymo Research Quick-RNA MiniPrep kit. 0.7 μg or
7 μg of total RNA from the supernatant or cells respectively was
separated on a 1.5% agarose–formaldehyde gel and transferred to a
nylon membrane. Membranes were originally probed for full length
and DI genomic RNA using an oligonucleotide [5′-ACAAGAAGACAA-
GAAAATTTAAAAGAATAAATATCTCTTAAACTCTTGTCTGGT-3′ (Inte-
grated DNA Technologies)] complimentary to the ﬁrst 54 5′-
nucleotides of the SeV genomic RNA. The primer was labeled with
[γ-32P]-ATP using bacteriophage T4 polynucleotide kinase (New
England Biolabs). Membranes were then reprobed for NP mRNA
using the riboprobe described above. Radioactive signals were
measured using a Typhoon 8600 Phosphorimager and ImageQuant
software (Molecular Dynamics).
Protein analysis
To compare the amounts of the P and L proteins in cell lysates used
for in vitro transcription, total protein samples from transfected
cytoplasmic lysates (5 μl out of 100 μl) were separated by 7.5% SDS-
PAGE and electroblotted onto a polyvinylidene diﬂuoride membrane
(PVDF, Sigma). Membranes were blocked with 5% non-fat dry milk in
TBST [0.5 MNaCl, 20 mM Tris pH (7.5), 0.1% Tween 20] and antibodies
were diluted in the same buffer. Blots were initially incubated with a
mixture of rabbit antibodies against the SeV L protein (a-TrpE-SeV-L
#5 (“1-19-90”) and a-TrpE-SeV-L #1 (“10-23-89”) (Horikami et al.,
1992), and developed with a horseradish peroxidase-conjugated
secondary antibody using the Enhanced Chemiluminescence Plus
protein detection system (GE Healthcare) in accordance with
manufacturer's instructions. Blots were then reprobed with a rabbit
anti-SeV antibody (“1-4-83”) (Carlsen et al., 1985) and developed in
the same manner. Protein bands were quantiﬁed using Vision-
WorksLS software (UVP).
Acknowledgments
We are grateful to Sue Moyer (University of Florida College of
Medicine) for providingmaterials for this project. We thankWolfgang
J. Neubert (Max-Planck-Institute of Biochemistry, Germany) for a kindgift of SeV plasmids. This work was supported by NIH grant
1R15GM084422 (to V. Z. G.).
References
Abraham, G., Rhodes, D.P., Banerjee, A.K., 1975. The 5′ terminal structure of the
methylated mRNA synthesized in vitro by vesicular stomatitis virus. Cell 5, 51–58.
Bollati, M., Milani, M., Mastrangelo, E., Ricagno, S., Tedeschi, G., Nonnis, S., Decroly, E.,
Selisko, B., de Lamballerie, X., Coutard, B., Canard, B., Bolognesi, M., 2009.
Recognition of RNA cap in the Wesselsbron virus NS5 methyltransferase domain:
implications for RNA-capping mechanisms in Flavivirus. J. Mol. Biol. 385, 140–152.
Bouvet,M.,Debarnot, C., Imbert, I., Selisko, B., Snijder, E.J., Canard,B., Decroly, E., 2010. Invitro
reconstitution of SARS-coronavirus mRNA cap methylation. PLoS Pathog. 6 (4),
e1000863.
Brodsky, L.I., Drachev, A.L., Leontovich, A.M., Feranchuk, S.I., 1993. A novel method of
multiple alignment of biopolymer sequences. Biosystems 30, 65–79.
Buchholz, U.J., Finke, S., Conzelmann, K.K., 1999. Generation of bovine respiratory
syncytial virus (BRSV) from cDNA: BRSV NS2 is not essential for virus replication in
tissue culture, and the human RSV leader region acts as a functional BRSV genome
promoter. J. Virol. 73, 251–259.
Bujnicki, J.M., Rychlewski, L., 2002. In silico identiﬁcation, structure prediction and
phylogenetic analysis of the 2′-O-ribose (cap 1) methyltransferase domain in the
large structural protein of ssRNA negative-strand viruses. Protein Eng. 15, 101–108.
Carlsen, S.R., Peluso, R.W., Moyer, S.A., 1985. In vitro replication of Sendai virus wild-
type and defective interfering particle genome RNAs. J. Virol. 54, 493–500.
Cartee, T.L., Megaw, A.G., Oomens, A.G., Wertz, G.W., 2003. Identiﬁcation of a single
amino acid change in the human respiratory syncytial virus L protein that affects
transcriptional termination. J. Virol. 77, 7352–7360.
Chandrika, R., Horikami, S.M., Smallwood, S., Moyer, S.A., 1995. Mutations in conserved
domain I of the Sendai virus L polymerase protein uncouple transcription and
replication. Virology 213, 352–363.
Cortese, C.K., Feller, J.A., Moyer, S.A., 2000. Mutations in domain V of the Sendai virus L
polymerase protein uncouple transcription and replication and differentially affect
replication in vitro and in vivo. Virology 277, 387–396.
Curran, J., Boeck, R., Kolakofsky, D., 1991. The Sendai virus P gene expresses both an
essential protein and an inhibitor of RNA synthesis by shufﬂing modules via mRNA
editing. EMBO J. 10, 3079–3085.
Decroly, E., Imbert, I., Coutard, B., Bouvet, M., Selisko, B., Alvarez, K., Gorbalenya, A.E.,
Snijder, E.J., Canard, B., 2008. Coronavirus nonstructural protein 16 is a cap-0
binding enzyme possessing (nucleoside-2′O)-methyltransferase activity. J. Virol.
82, 8071–8084.
Duprex, W.P., Collins, F.M., Rima, B.K., 2002. Modulating the function of the measles
virus RNA-dependent RNA polymerase by insertion of green ﬂuorescent protein
into the open reading frame. J. Virol. 76, 7322–7328.
Egloff, M.P., Decroly, E., Malet, H., Selisko, B., Benarroch, D., Ferron, F., Canard, B., 2007.
Structural and functional analysis of methylation and 5′-RNA sequence require-
ments of short capped RNAs by the methyltransferase domain of dengue virus NS5.
J. Mol. Biol. 372, 723–736.
Ferron, F., Longhi, S., Henrissat, B., Canard, B., 2002. Viral RNA-polymerases — a
predicted 2′-O-ribose methyltransferase domain shared by all Mononegavirales.
Trends Biochem. Sci. 27, 222–224.
Fuerst, T.R., Niles, E.G., Studier, F.W., Moss, B., 1986. Eukaryotic transient-expression
system based on recombinant vaccinia virus that synthesizes bacteriophage T7
RNA polymerase. Proc. Natl. Acad. Sci. U. S. A. 83, 8122–8126.
Galloway, S.E., Richardson, P.E., Wertz, G.W., 2008. Analysis of a structural homology
model of the 2′-O-ribose methyltransferase domain within the vesicular stomatitis
virus L protein. Virology 382, 69–82.
Gingras, A.C., Raught, B., Sonenberg, N., 1999. eIF4 initiation factors: effectors of mRNA
recruitment to ribosomesandregulatorsof translation.Annu.Rev.Biochem.68, 913–963.
Grdzelishvili, V.Z., Smallwood, S., Tower, D., Hall, R.L., Hunt, D.M., Moyer, S.A., 2005. A
single amino acid change in the L-polymerase protein of vesicular stomatitis virus
completely abolishes viral mRNA cap methylation. J. Virol. 79, 7327–7337.
Grdzelishvili, V.Z., Smallwood, S., Tower, D., Hall, R.L., Hunt, D.M., Moyer, S.A., 2006.
Identiﬁcation of a new region in the vesicular stomatitis virus L polymerase protein
which is essential for mRNA cap methylation. Virology 350, 394–405.
Hercyk, N., Horikami, S.M., Moyer, S.A., 1988. The vesicular stomatitis virus L protein
possesses the mRNA methyltransferase activities. Virology 163, 222–225.
Horikami, S.M., Moyer, S.A., 1982. Host range mutants of vesicular stomatitis virus
defective in in vitro RNA methylation. Proc. Natl. Acad. Sci. U. S. A. 79, 7694–7698.
Horikami, S.M., De Ferra, F., Moyer, S.A., 1984. Characterization of the infections of
permissive and nonpermissive cells by host range mutants of vesicular stomatitis
virus defective in RNA methylation. Virology 138, 1–15.
Horikami, S.M., Curran, J., Kolakofsky, D., Moyer, S.A., 1992. Complexes of Sendai virus
NP-P and P-L proteins are required for defective interfering particle genome
replication in vitro. J. Virol. 66, 4901–4908.
Kozbial, P.Z., Mushegian, A.R., 2005. Natural history of S-adenosylmethionine-binding
proteins. BMC Struct. Biol. 5, 19.
Lamb, R.A., Parks, G.D., 2007. Paramyxoviridae: the viruses and their replication, In:
Knipe, D.M., Howley, P.M. (Eds.), Fields Virology, 5th edition. Lippincott Williams &
Wilkins, Philadelphia, pp. 1449–1496.
Leyrer, S., Neubert,W.J., Sedlmeier, R., 1998. Rapid andefﬁcient recoveryof Sendai virus from
cDNA: factors inﬂuencing recombinant virus rescue. J. Virol. Methods 75, 47–58.
Li, J., Fontaine-Rodriguez, E.C., Whelan, S.P., 2005. Amino acid residues within
conserved domain VI of the vesicular stomatitis virus large polymerase protein
essential for mRNA cap methyltransferase activity. J. Virol. 79, 13373–13384.
382 A.M. Murphy et al. / Virology 405 (2010) 370–382Li, J., Wang, J.T., Whelan, S.P., 2006. A unique strategy for mRNA cap methylation used
by vesicular stomatitis virus. Proc. Natl. Acad. Sci. U. S. A. 103, 8493–8498.
Li, J., Rahmeh, A., Morelli, M., Whelan, S.P., 2008. A conserved motif in region v of the
large polymerase proteins of nonsegmented negative-sense RNA viruses that is
essential for mRNA capping. J. Virol. 82, 775–784.
Lyles, D.S., Rupprecht, C.E., 2007. Rhabdoviridae, In: Knipe, D.M., Howley, P.M. (Eds.), Fields
Virology, 5th edition. Lippincott Williams &Wilkins, Philadelphia, pp. 1363–1408.
Martin, J.L., McMillan, F.M., 2002. SAM (dependent) I AM: the S-adenosylmethionine-
dependent methyltransferase fold. Curr. Opin. Struct. Biol. 12, 783–793.
Murphy, A.M., Grdzelishvili, V.Z., 2009. Identiﬁcation of sendai virus L protein amino
acid residues affecting viral mRNA cap methylation. J. Virol. 83, 1669–1681.
Ogino, T., Banerjee, A.K., 2010. The HR motif in the RNA-dependent RNA polymerase L
protein of Chandipura virus is required for unconventional mRNA-capping activity.
J. Gen. Virol. 91, 1311–1314.
Ogino, T., Kobayashi, M., Iwama, M., Mizumoto, K., 2005. Sendai virus RNA-dependent
RNA polymerase L protein catalyzes cap methylation of virus-speciﬁc mRNA. J. Biol.
Chem. 280, 4429–4435.
Ogino, T., Yadav, S.P., Banerjee, A.K., 2010. Histidine-mediated RNA transfer to GDP for
unique mRNA capping by vesicular stomatitis virus RNA polymerase. Proc. Natl.
Acad. Sci. U. S. A. 107, 3463–3468.
Poch, O., Blumberg, B.M., Bougueleret, L., Tordo, N., 1990. Sequence comparison of ﬁve
polymerases (L proteins) of unsegmented negative-strand RNA viruses: theoretical
assignment of functional domains. J. Gen. Virol. 71, 1153–1162.
Rahmeh, A.A., L.J., Kranzusch, P.J., Whelan, S.P., 2009. Ribose 2′-O methylation of the
vesicular stomatitis virus mRNA cap precedes and facilitates subsequent guanine-
N-7 methylation by the large polymerase protein. J. Virol. 83, 11043–11050.
Ray, D., Shah, A., Tilgner, M., Guo, Y., Zhao, Y., Dong, H., Deas, T.S., Zhou, Y., Li, H., Shi, P.Y.,
2006. West Nile virus 5′-cap structure is formed by sequential guanine N-7 and
ribose 2′-O methylations by nonstructural protein 5. J. Virol. 80, 8362–8370.Ruedas, J.B., Perrault, J., 2009. Insertion of enhanced green ﬂuorescent protein in a hinge
region of vesicular stomatitis virus L polymerase protein creates a temperature-
sensitive virus that displays no virion-associated polymerase activity in vitro. J.
Virol. 83, 12241–12252.
Schnell, M.J., Conzelmann, K.K., 1995. Polymerase activity of in vitro mutated rabies
virus L protein. Virology 214, 522–530.
Selisko, B., Peyrane, F.F., Canard, B., Alvarez, K., Decroly, E., 2010. Biochemical
characterization of the (nucleoside-2′O)-methyltransferase activity of dengue
virus protein NS5 using puriﬁed capped RNA oligonucleotides (7Me)GpppAC(n)
and GpppAC(n). J. Gen. Virol. 91, 112–121.
Shinshi, H., Miwa, M., Sugimura, T., 1976. Enzyme cleaving the 5′-terminal methylated
blocked structure of messenger RNA. FEBS Lett. 65, 254–257.
Sidhu, M.S., Menonna, J.P., Cook, S.D., Dowling, P.C., Udem, S.A., 1993. Canine distemper
virus L gene: sequence and comparison with related viruses. Virology 193, 50–65.
Sleat, D.E., Banerjee, A.K., 1993. Transcriptional activity and mutational analysis of
recombinant vesicular stomatitis virus RNA polymerase. J. Virol. 67, 1334–1339.
Smallwood, S., Hovel, T., Neubert, W.J., Moyer, S.A., 2002. Different substitutions at
conserved amino acids in domains II and III in the Sendai L RNA polymerase protein
inactivate viral RNA synthesis. Virology 304, 135–145.
Takagi, T., Muroya, K., Iwama, M., Shioda, T., Tsukamoto, T., Mizumoto, K., 1995. In vitro
mRNA synthesis by Sendai virus: isolation and characterization of the transcription
initiation complex. J. Biochem. (Tokyo) 118, 390–396.
Testa, D., Banerjee, A.K., 1977. Twomethyltransferase activities in the puriﬁed virions of
vesicular stomatitis virus. J. Virol. 24, 786–793.
Whelan, S.P., Barr, J.N., Wertz, G.W., 2004. Transcription and replication of nonsegmented
negative-strand RNA viruses. Curr. Top. Microbiol. Immunol. 283, 61–119.
Zhou, Y., Ray, D., Zhao, Y., Dong, H., Ren, S., Li, Z., Guo, Y., Bernard, K.A., Shi, P.Y., Li, H.,
2007. Structure and function of ﬂavivirus NS5 methyltransferase. J. Virol. 81,
3891–3903.
